SCHEMBL8616936

SCHEMBL8616936

O=C(O)c1cn(C2CC2)c2c(F)c(N3CCNCC3)c(F)cc2c1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.66
TOP2A P11388 6/20 0.66
TOP2B Q02880 6/20 0.66
KDM4E B2RXH2 5/20 0.66
HPGD P15428 5/20 0.66
HSD17B10 Q99714 5/20 0.66
LMNA P02545 2/20 0.66
CYP1A2 P05177 1/20 0.66
CYP2C9 P11712 1/20 0.66
KCNH2 Q12809 5/20 0.64
POLB P06746 2/20 0.64
OPRM1 P35372 2/20 0.64
PRKD3 O94806 1/20 0.64
ALOX15 P16050 1/20 0.64
CLK2 P49760 1/20 0.64
CLK4 Q9HAZ1 1/20 0.64
TDP1 Q9NUW8 1/20 0.64
CHRM2 P08172 1/20 0.58
CHRM1 P11229 1/20 0.58
OPRD1 P41143 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29638251 1.00 ALDH1A1 (0.66) ALDH1A1TOP2ATOP2BKDM4EHPGD
Hydrochloric Acid SCHEMBL10400652 0.99 ALDH1A1 (0.65) ALDH1A1TOP2ATOP2BKDM4EHPGD
SCHEMBL9676493 0.92 KCNH2 (0.68) ALDH1A1TOP2ATOP2BKDM4EHPGD
Hydrochloric Acid SCHEMBL9023708 0.91 KCNH2 (0.67) ALDH1A1TOP2ATOP2BKDM4EHPGD
SCHEMBL10785816 0.90 TOP2A (0.62) ALDH1A1TOP2ATOP2BKDM4EHPGD
SCHEMBL9668066 0.90 TOP2A (0.62) ALDH1A1TOP2ATOP2BKDM4EHPGD
SCHEMBL10351473 0.90 TOP2A (0.64) ALDH1A1TOP2ATOP2BKDM4EHPGD
SCHEMBL5570963 0.90 ALDH1A1 (0.72) ALDH1A1TOP2ATOP2BKDM4EHPGD
SCHEMBL8433503 0.90 TOP2A (0.58) ALDH1A1TOP2ATOP2BKDM4EHPGD
SCHEMBL10790810 0.89 TOP2A (0.61) ALDH1A1TOP2ATOP2BKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0126355-B1 7-AMINO-1-CYCLOPROPYL-6,8-DIFLUORO-1,4-DIHYDRO-4-OXO-3-QUINOLINE-CARBOXYLIC ACID, PROCESSES FOR THEIR PREPARATION AND ANTIBACTERIAL AGENTS CONTAINING THEM BAYER AG (DE) 1987-09-09 EP claimed
US-4659603-A 1-CYCLOPROPYLQUINOLONE-3-CARBOXYLIC ACIDS BAYER AKTIENGESELLSCHAFT (DE) 1987-04-21 US claimed
US-4556658-A 7-Amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acids and antibacterial agents containing these compounds BAYER AKTIENGESELLSCHAFT (DE) 1985-12-03 US claimed
EP-0126355-A1 7-Amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3-quinoline-carboxylic acid, processes for their preparation and antibacterial agents containing them BAYER AG (DE) 1984-11-28 EP claimed
JP-60126271-A None JP disclosed
JP-60178867-A None JP disclosed
US-20090306035-A1 Compounds and Methods for modulating the Silencing of a Polynucleotide of Interest EMORY UNIVERSITY (US) 2009-12-10 US disclosed
US-20090306035-A1 Compounds and Methods for modulating the Silencing of a Polynucleotide of Interest EMORY UNIVERSITY (US) 2009-12-10 US disclosed
EP-0659763-B1 21-Hydroxy pregnane - Quinoline carboxylic acid esters and Antibacterial and Antiinflammatory compositions containing them SENJU PHARMA CO (JP) 1998-05-20 EP disclosed
US-5753658-A FOR TREATMENT OF BACTERIAL INFECTIONS SENJU PHARMACEUTICAL CO., LTD. (JP) 1998-05-19 US disclosed
US-5672600-A Antimicrobial dithiocarbamoyl quinolones THE PROCTER & GAMBLE COMPANY (US) 1997-09-30 US disclosed
EP-0793656-A1 NOVEL BENZYL PYRIMIDINES F. HOFFMANN-LA ROCHE AG (CH) 1997-09-10 EP disclosed
EP-0200307-A1 Improved process for production of quinoline-3-carboxylic acid antibacterial agents WARNER-LAMBERT COMPANY (US) 1986-11-05 EP disclosed
EP-0191185-A1 Quinoline-carboxylic acid derivatives DAIICHI SEIYAKU CO., LTD. (JP) 1986-08-20 EP disclosed
US-4578473-A Process for quinoline-3-carboxylic acid antibacterial agents WARNER-LAMBERT COMPANY (US) 1986-03-25 US disclosed
US-4556658-A 7-Amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acids and antibacterial agents containing these compounds BAYER AKTIENGESELLSCHAFT (DE) 1985-12-03 US disclosed
JP-S60178867-A DIHALOGENOQUINOLINE DERIVATIVE DAI ICHI SEIYAKU CO LTD 1985-09-12 JP disclosed
EP-0153828-A2 1-cyclopropyl-1, 4-dihydro-6-fluoro-4-oxo-1, 8-naphthyridine-3-carboxylic acids; their derivatives and a process for preparing the compounds WARNER-LAMBERT COMPANY (US) 1985-09-04 EP disclosed
JP-S60126271-A QUINOLONECARBOXYLIC ACID DERIVATIVE KYORIN PHARMACEUT CO LTD 1985-07-05 JP disclosed
EP-0126355-A1 7-Amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3-quinoline-carboxylic acid, processes for their preparation and antibacterial agents containing them BAYER AG (DE) 1984-11-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306035-A1 Compounds and Methods for modulating the Silencing of a Polynucleotide of Interest SNRPE, NSUN2, SNRPA ALDH1A1 3615/4885TOP2A 1071/4885TOP2B 998/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.